Prestige Consumer Healthcare Inc (PBH) Company Profile & Statistics

Prestige Consumer Healthcare Inc
PBH
(NYSE)
N/A
70.10
-0.03 (-0.04%)
in:usd•As of: Apr 25, 2024 15:59 UTC -4
Open
70.38
High
70.40
Low
69.19

About Prestige Consumer Healthcare Inc

CEO

Ronald M. Lombardi

Headquarters

660 white plains road, suite 250

tarrytown, ny 10591, united states

Auditor

PricewaterhouseCoopers LLP

Employees

560

Share Holders

Website

www.prestigebrands.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.

Prestige Consumer Healthcare Inc Statistics

Valuation Measures

Market Capitalization ²	3.48B
Enterprise Value	4.62B
Enterprise Value/EBITDA (ttm)	298.92
Price to Earnings Ratio (ttm)	16.72
Price to Book (mrq)	2.21
Price to Sales (ttm)	3.12
Price to Cash (ytd)	14.21

Profitability

Gross Margin (ttm)	55.23%
Operating Margin (ttm)	18.83%
Profit Margin (ttm)	-6.90%
Return on Equity (ttm)	14.09%
Return on Invested Capital (ttm)	-2.90%
Return on Assets (ttm)	6.39%

Income Statement

Revenue (ttm)	1.13B
Revenue Per Share (ttm)	22.84
Gross Profit (ttm)	626.39M
EBITDA (ttm)³	15.45M
Net Income Avi to Common (ttm)	-80.67M
Diluted EPS (ttm)	-1.64

Share Statistics

Beta (5Y Monthly)	0.52
52-Week Change	14.10%
S&P500 52-Week Change	23.99%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	49.65M
Dividend Yield	0.00%
Float ⁴	48.85M
% Held by Insiders	1.60%
% Held by Institutions	99.95%

Balance Sheet

Total Cash (mrq)	63.62M
Total Cash Per Share (mrq)	1.28
Total Debt (mrq)	1.20B
Total Debt/Equity (mrq)	75.08%
Current Ratio (mrq)	3.09%
Quick Ratio (mrq)	1.92%
Book Value Per Share (mrq)	32.24

Cash Flow

Operating Cash Flow Per Share (ytd)	3.63
Free Cash Flow (ytd)	175.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Prestige Consumer Healthcare Inc

Trade With A Regulated Broker